MD2354F1 - Method of treatment of the hepatic encephalopathy - Google Patents

Method of treatment of the hepatic encephalopathy

Info

Publication number
MD2354F1
MD2354F1 MD20030191A MD20030191A MD2354F1 MD 2354 F1 MD2354 F1 MD 2354F1 MD 20030191 A MD20030191 A MD 20030191A MD 20030191 A MD20030191 A MD 20030191A MD 2354 F1 MD2354 F1 MD 2354F1
Authority
MD
Moldova
Prior art keywords
treatment
during
hepatic encephalopathy
ozone
reologic
Prior art date
Application number
MD20030191A
Other languages
Romanian (ro)
Other versions
MD2354G2 (en
Inventor
Boris Pirgari
Constantin Tibirna
Gheorghe Anghelici
Veaceslav Tacu
Viorel Moraru
Original Assignee
Boris Pirgari
Constantin Tibirna
Gheorghe Anghelici
Veaceslav Tacu
Viorel Moraru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boris Pirgari, Constantin Tibirna, Gheorghe Anghelici, Veaceslav Tacu, Viorel Moraru filed Critical Boris Pirgari
Priority to MDA20030191A priority Critical patent/MD2354G2/en
Publication of MD2354F1 publication Critical patent/MD2354F1/en
Publication of MD2354G2 publication Critical patent/MD2354G2/en

Links

Abstract

The invention refers to medicine, in particular to ozonotherapy and hepatology, and may be used for intensive therapy of precomatose states and comas in case of hepatic cirrhosis. Summary of the method consists in that intravenously is administered as reologic substance the ozonized 0,9% solution of NaCl, containing 2000...4000 ?g/L of ozone, during 8...10 procedures. Moreover, into the intestine through the probe it is introduced ozone in concentration of 6000...8000 ?g/L in a volume of 300...500 cm3 daily, during 10...12 days. Concomitantly, it is carried out the symptomatic treatment.Claims: 1
MDA20030191A 2003-07-29 2003-07-29 Method of treatment of the hepatic encephalopathy MD2354G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030191A MD2354G2 (en) 2003-07-29 2003-07-29 Method of treatment of the hepatic encephalopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030191A MD2354G2 (en) 2003-07-29 2003-07-29 Method of treatment of the hepatic encephalopathy

Publications (2)

Publication Number Publication Date
MD2354F1 true MD2354F1 (en) 2004-01-31
MD2354G2 MD2354G2 (en) 2004-07-31

Family

ID=32065048

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030191A MD2354G2 (en) 2003-07-29 2003-07-29 Method of treatment of the hepatic encephalopathy

Country Status (1)

Country Link
MD (1) MD2354G2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2551G2 (en) * 2003-12-03 2005-03-31 Андрей ПЫРГАРЬ Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses
MD2933G2 (en) * 2005-06-23 2006-08-31 Виктор ГИКАВЫЙ Method of treatment of the skin affections

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3477G2 (en) * 2007-03-21 2008-08-31 Николае БОДРУГ Method of treating the chronic viral hepatitis C
MD3555G2 (en) * 2007-11-01 2008-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of hepatic encephalopathy treatment

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2551G2 (en) * 2003-12-03 2005-03-31 Андрей ПЫРГАРЬ Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses
MD2933G2 (en) * 2005-06-23 2006-08-31 Виктор ГИКАВЫЙ Method of treatment of the skin affections

Also Published As

Publication number Publication date
MD2354G2 (en) 2004-07-31

Similar Documents

Publication Publication Date Title
EA200600820A1 (en) METHODS OF TREATMENT, MODIFICATION AND ELIMINATION OF PATIENTS USING 1-OXO-2- (2,6-DIOXOPYPERIDIN-3-IL) -4-METHYLISYNDOLINE
ATE489956T1 (en) FORMULATIONS CONTAINING SALICYLATES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
NZ544645A (en) Use of calcitonin in osteoarthritis
EA200500124A1 (en) METHOD AND APPARATUS FOR INTRODUCTION OF CARBON MONOXIDE TO THE ORGANISM
ATE418994T1 (en) INHALATION MEDICINAL CONTAINING ARGONE AND USE THEREOF FOR THE TREATMENT OF NEUROTOXICITY
DE60218193D1 (en) USE OF 2-OXO-1-PYRROLIDINE DERIVATIVES FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF DYSKINESIA
NO20081149L (en) Method of Treating B-Cell Malignancies Using TACI-IG Fusion Molecule
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
MXPA06007510A (en) Novel drug compositions and dosage forms of topiramate.
MD2354F1 (en) Method of treatment of the hepatic encephalopathy
RU2006119263A (en) METHOD FOR TREATING PATIENTS WITH ROSATSEA
RU2006126294A (en) METHOD FOR TREATING PATIENTS WITH CHRONIC FORMS OF PERIODONTITIS AND PERIODONTITIS IN THE STAGE OF EXCESSION
MD2211F1 (en) Remedy for treatment of parodontium affections
MD2327F1 (en) Method of treatment of parodontium affections
MD2375F1 (en) Method of portal gastropathy treatment in hepatic cirrhosis
MD2210F1 (en) Method of treatment of parodontitis
RU2003135123A (en) METHOD FOR TREATING DRUG DEPENDENCIES
RU2249451C2 (en) Method for treating acute purulent inflammation in serous cavity
RU2313373C1 (en) Method for treating chronic diseases of large intestine accompanied with constipation syndrome in children
RU2003133804A (en) METHOD OF AUTOANALGESIA XENON-OXYGEN MIXTURE
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
Zamora et al. Inhibition of tumor necrosis factor-alpha release during endotoxic shock by ozone oxidative preconditioning in mice
RU2000108520A (en) METHOD FOR RESTORING TREATMENT OF OSTEOARTHROSIS PATIENTS
MD2871F1 (en) Method of treatment of the secondary purulent meningitis
RU2003135189A (en) METHOD FOR PREVENTION OF INFECTIOUS INFLAMMATORY COMPLICATIONS IN PATIENTS WITH Urolithiasis DURING TREATMENT BY THE METHOD OF REMOTE LITHOTRIPSY

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees